XOMA Royalty Corporation (XOMAP) support and resistance · P/E 25, rev $28.5M
XOMA Royalty Corporation (XOMAP) is a biotechnology company listed on NASDAQ.
This page maps XOMA Royalty Corporation (XOMAP) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported XOMAP revenue for 2024-12-31 was $28.5M. Net income was -$13.8M. Revenue was up 498.7% from 2023-12-31 to 2024-12-31. XOMAP currently screens at market cap $0 and trailing P/E 25.4.
XOMAP currently screens at market cap $0 and trailing P/E 25.4. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new XOMAP 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the XOMAP quote page for the session range and the stock page for the full model.
Not investment advice.